Gameday Men’s Health Metairie（Metairie, LA）

Gameday Men’s Health Metairie opened in 2024 to address the growing demand for specialized men’s health services in the greater New Orleans metropolitan area. Located in Metairie, Louisiana, the clinic focuses exclusively on male hormonal optimization, sexual health restoration, and metabolic wellness through evidence-based protocols that combine hormone replacement therapy with targeted peptide interventions. The clinic serves men throughout Jefferson Parish and surrounding communities who seek clinical solutions for low testosterone, erectile dysfunction, and weight management challenges that impact quality of life and performance.

The treatment portfolio at Gameday Men’s Health Metairie centers on testosterone replacement therapy complemented by two specific peptide protocols: PT-141 (bremelanotide) for erectile dysfunction and Sermorelin for growth hormone optimization. PT-141 works through melanocortin receptor activation to enhance sexual arousal and function independent of vascular mechanisms, offering an alternative for men who have not responded adequately to PDE5 inhibitors or who have contraindications to traditional ED medications. Sermorelin, a growth hormone-releasing hormone analog, stimulates the pituitary gland to increase natural growth hormone production, supporting improved body composition, energy levels, and metabolic function as part of comprehensive weight loss programs. Testosterone therapy protocols are individualized based on comprehensive lab work and symptom assessment, with options including injectable, topical, and pellet delivery systems tailored to patient preference and physiological response.

The clinic’s approach integrates initial comprehensive evaluation with ongoing monitoring to optimize treatment outcomes and minimize potential side effects. New patients undergo detailed health history review, physical examination, and laboratory testing that includes total and free testosterone, estradiol, complete blood count, comprehensive metabolic panel, lipid profile, and PSA screening. Follow-up protocols include regular lab monitoring and clinical assessments to adjust dosing and ensure therapeutic testosterone levels are maintained within optimal ranges. For erectile dysfunction treatment, providers evaluate cardiovascular health, medication interactions, and underlying causes to determine whether PT-141 peptide therapy, testosterone optimization, or combination approaches will deliver the best results. Weight loss programs combine Sermorelin peptide therapy with nutritional guidance and lifestyle modification strategies designed specifically for male metabolic patterns.

Gameday Men’s Health Metairie provides both in-person consultations at the Metairie location and telehealth appointments for established patients and initial consultations when appropriate. In-person visits allow for physical examination, injection training, and hands-on patient education, while telehealth options provide convenient access for follow-up appointments, lab review, and treatment adjustments for patients with scheduling constraints or those traveling from surrounding areas including Kenner, New Orleans, and the Northshore. The clinic’s patient experience emphasizes straightforward communication about treatment expectations, realistic timelines for symptom improvement, and transparent discussion of costs and insurance considerations. Most patients begin noticing improvements in energy and mood within 3-6 weeks of initiating testosterone therapy, with full benefits typically emerging over 3-6 months of consistent treatment.

With a 4.9-star rating from 18 Google reviews, Gameday Men’s Health Metairie has established credibility in the competitive Metairie men’s health market despite opening recently in 2024. The clinic differentiates itself through its focused scope of practice—treating only men’s hormonal and sexual health rather than operating as a general wellness center—and its integration of peptide therapies alongside traditional hormone replacement. This specialization allows providers to develop deep expertise in male endocrinology and sexual medicine rather than spreading clinical focus across multiple demographic groups or treatment categories. The availability of both PT-141 and Sermorelin expands treatment options beyond testosterone alone, addressing the reality that many men experience multiple concurrent issues including low libido, erectile dysfunction, fatigue, and weight gain that benefit from multi-modal therapeutic approaches.